BioVex Ltd.

United States : BioVex Raises $30 Million.
TendersInfo; 11/11/2009; 753 words; ...Science Partners will join the BioVex board of directors. Securing...significant milestone that puts BioVex in a strong financial position...Sparke, President and CEO of BioVex. We believe this over-subscribed...Copyright : Euclid Infotech Pvt. Ltd. Provided by Syndigate.info...

Other News To Note.
BIOWORLD Today; 11/4/2009; 1733 words; ...approval in October. o BioVex Ltd., of Oxford, UK, signed...of an HIV vaccine using BioVex's ImmunoVEX herpes simplex...response to the virus. BioVex will provide an ImmunoVEX...Fujisawa Pharmaceutical Co. Ltd., of Osaka, Japan...

Sucampo, BioVex Line Up To Take Shot At Public Markets.
BIOWORLD Today; 11/3/2009; 890 words; ...up to $86.25 million, and BioVex Inc., which hopes to raise...with Takeda Pharmaceutical Co. Ltd., of Osaka, Japan, Amitiza...Cambridge, Mass.-based BioVex Inc., which is focused on...tumor deposits. In February, BioVex said the first patients in its...

Agennix Reports Positive NSCLC Data With Talactoferrin, Chemo.
BIOWORLD Today; 11/3/2009; 2431 words; ...equivalent or greater efficacy in xenograft models of human cancer. ARRY-334543 is in regulated safety assessment. o BioVex Ltd., of Oxford, UK, presented details of its recent Phase I/II trial of OncoVEX, an oncolytic virus designed to selectively...

Adprotech Being Acquired By Inflazyme In C$20M Deal.
BIOWORLD Today; 11/3/2009; 1103 words; ...shareholders in privately held Adprotech Ltd. agreed to be taken over by Inflazyme Pharmaceuticals Ltd. for about C$20 million (US$14.9...000 per month. McBeath, who was CEO of BioVex Ltd., of Oxford, UK, before he joined Inflazyme...